Trial intelligence / Profile preview

Hyperpolarized Helium-3 MRI for Lung Function in Children

NCT02163681Completed

Sponsor
University of Virginia
Start
Jan 2011
Primary completion
Jun 2018
Modality
Device-based Delivery
Countries
1
01

Overview

Open-label, single-arm trial of hyperpolarized helium-3, sponsored by University of Virginia. Primary endpoint: Ventilation Defects as Seen on Hyperpolarized Helium-3 MRI at Day 1. Started Jan 2011; status: completed.

02

Drugs

hyperpolarized helium-3

Beyond the preview

Go deeper on NCT02163681.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02163681.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call